Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (603)	7/1/1999 2:28:00 PM
From: Dr. John M. de Castro	Read Replies (2) \| Respond to of 1494

Paul Freiman- Panelist on biotech consolidation. Russell-Welsh Hosts Bay Area Biomedical Investment Conference July 7th and 8th SAN MATEO, Calif., Jul 1, 1999 (BW HealthWire via COMTEX) -- Dr. Laura Tyson, Former Clinton Economic Advisor and Current Dean of the Haas School of Business, to Moderate Panel Discussion on Consolidation Next week, Russell-Welsh, Inc., a Bay Area life science communications firm, will be hosting the Bay Area Biomedical Investment Conference at the San Mateo Marriott. The free conference, which features 21 local public and private biotechnology companies, is open to buy-side and sell-side analysts, institutional investors, portfolio managers, venture capitalists and members of the media. Dr. Laura Tyson, former chief economic advisor to President Clinton and current dean of the Haas School of Business at the University of California-Berkeley, will moderate a panel discussion focusing on consolidation in the biotechnology industry. Panelists include: Paul Freiman, president and CEO of Neurobiological Technologies; John Walker, chairman and CEO of Axys Pharmaceuticals; Kurt von Emster, portfolio manager for Franklin Templeton; Michael Becker, portfolio manager for Wayne Hummer Investments and editor of the monthly newsletter Beck on Biotech; and Teresa Corbin, partner of the law firm Howrey and Simon.